Arcturus Therapeutics Holdings Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ARCT Company Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
ARCT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ARCT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ARCT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ARCT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ARCT in WallStreetBets Daily Discussion
ARCT News
Recent insights relating to ARCT
CNBC Recommendations
Recent picks made for ARCT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ARCT
Corporate Flights
Flights by private jets registered to ARCT
Our Analysis